Reuters logo
BRIEF-Cadila Healthcare says Zydus' unit gets FDA nod for influenza drug
February 27, 2017 / 6:56 AM / 10 months ago

BRIEF-Cadila Healthcare says Zydus' unit gets FDA nod for influenza drug

Feb 27 (Reuters) - Cadila Healthcare Ltd

* Says Zydus’ Nesher Pharmaceuticals receives final approval from USFDA for oseltamivir phosphate capsules

* Says drug to be produced at Nesher Pharmaceuticals USA manufacturing facility

* Says oseltamivir phosphate is an anti-viral used in prevention, treatment of influenza virus infection

* Says group also got final FDA nod to market Linezolid tablets

* Says linezolid tabs USP is anti bacterial agent

* Says Linezolid tablets will be produced at formulations manufacturing facility at pharma SEZ in Ahmedabad Source text: bit.ly/2ml6jSm Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below